The FDA reviews drug approval decisions that are expected in March 2025. The FDA is reviewing the application for bentracimab for use as a ticagrelor reversal agent in patients with uncontrolled ...

Here's what macular degeneration is, what causes it and how you can expect it to be treated if it affects you or a loved one.

Martin Friedlander, MD, PhD, discusses phase 3 macular telangiectasia findings, highlighting the potential for a decade-long ...

The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.

A study found that injecting mesenchymal stem cells into periocular tissue effectively reduces eye inflammation without ...

As Valentine’s Day approaches, it turns out love really can be the best medicine - not just for your heart but for your overall well-being, according to health experts.

In this Healio Video Perspective from Hawaiian Eye 2025, I. Paul Singh, MD, discusses the AquaLumen, a subconjunctival bypass technology to lower IOP in patients with glaucoma.

Light adjustable lenses have strong visual and refractive outcomes in patients who have previously undergone radial keratotomy.

Standalone canaloplasty and trabeculotomy can deliver meaningfully reduced IOP in the long term and require fewer topical therapy agents.